Intervention to reduce violence and improve HIV care in young Black men and transgender women
#ChopViolence/#ChopHIV: A Tailored Violence Prevention Intervention for Black Young MSM and Transgender Women From the House Ball Community to Improve HIV Outcomes and Decrease Exposure to Violence
This study is testing a new program to see if it can help reduce violence and improve HIV care for young Black men and transgender women in Chicago's House Ball Community.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 525 (estimated) |
| Ages | 15 Years to 29 Years |
| Sex | Male |
| Sponsor | Hektoen Institute for Medical Research Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT04769492 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on Black young gay, bisexual, and other men who have sex with men (B-YGBMSM) and transgender women (B-YTW) who are at high risk for HIV/AIDS. It aims to address the cycle of violence within the House Ball Community (HBC) in Chicago, which serves as a crucial social network for these individuals. By tailoring the Cure Violence model to be culturally specific and developmentally appropriate, the study seeks to enhance access to HIV services and care. The intervention will be pilot tested at HBC events to evaluate its effectiveness in reducing violence and improving health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are Black individuals aged 15-29 who identify as gay, bisexual, or transgender and are involved in the House Ball Community.
Not a fit: Patients who do not identify as Black or are outside the age range of 15-29 may not receive benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve access to HIV care and reduce violence among at-risk youth in the Black gay community.
How similar studies have performed: While similar interventions have been explored, this specific approach tailored to the HBC community is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. self-identified as Black, 2. ages 15-29 3. in attendance at a HBC event at the time of the assessment. Exclusion Criteria: -
Where this trial is running
Chicago, Illinois
- Cook County Health — Chicago, Illinois, United States (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.